Remedy: Potential unchanged despite short-term bumps on the road
The key takeaway from Remedy's Q2 report was that the extra time taken for Vanguard was not due to problems with the project, but a conscious decision by Remedy to try to maximize the game's long-term potential for success. At the same time, the company's recruitment and investments in external game development have progressed faster than expected, which is reflected in our lower earnings forecasts for the next few years. Despite the short-term bumps, we still believe that Remedy's stock will at some point begin to more strongly anticipate the earnings potential of current projects, against which the valuation of the stock is moderate
Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.
Read more on company pageKey Estimate Figures15.08.2022
| 2021 | 22e | 23e | |
|---|---|---|---|
| Revenue | 44.7 | 43.7 | 46.2 |
| growth-% | 8.9 % | -2.4 % | 5.8 % |
| EBIT (adj.) | 11.4 | -1.4 | -2.5 |
| EBIT-% (adj.) | 25.5 % | -3.3 % | -5.5 % |
| EPS (adj.) | 0.67 | -0.15 | -0.16 |
| Dividend | 0.17 | 0.17 | 0.17 |
| Dividend % | 0.4 % | 1.1 % | 1.1 % |
| P/E (adj.) | 59.0 | neg. | neg. |
| EV/EBITDA | 33.0 | 163.1 | 3,287.0 |
Forum discussions
